Irinotecan in Treating Children With Refractory Solid Tumors

This study has been completed.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Neuroblastoma
			Sarcoma
2		Additional conditions recognized in this trial
			Central Nervous System Neoplasms
			Nervous System Neoplasms
3		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Connective and Soft Tissue
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Glandular and Epithelial
			Neoplasms, Nerve Tissue
			Neoplasms, Neuroepithelial
			Nervous System Diseases
			Neuroectodermal Tumors
			Neuroectodermal Tumors, Primitive
			Neuroectodermal Tumors, Primitive, Peripheral
4		Interventions listed in this trial
			irinotecan hydrochloride
5		Additional drug interventions recognized in this trial
			Camptothecin
			Irinotecan
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Children's Oncology Group
			National Cancer Institute (NCI)